Literature DB >> 7119132

An investigation of drug expectancy as a function of capsule color and size and preparation form.

L W Buckalew, K E Coffield.   

Abstract

Much of a drug response is related to nonspecific factors. Perceptual characteristics of drug preparations likely play a major role in expectancy and response. This study focused on perceptual characteristics of a preparation related to anticipated effect: capsule color, capsule size, and preparation form (capsule versus tablet). College students ranked capsules for perceived strength based on capsule size, categorized capsules in terms of anticipated pharmacological effect based on color, and evaluated strength based on preparation form. Data showed nonchance distributions for nine capsule colors in anticipated action, with specific effects for four colors. A significant difference between capsule and tablet for perceived strength was found, as was a trend relating capsule size to perceived drug strength. Discussion centered on awareness and consideration of drug perceptual characteristics in support of drug efficacy.

Mesh:

Substances:

Year:  1982        PMID: 7119132

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  18 in total

1.  Are the colors and shapes of current psychotropics designed to maximize the placebo response?

Authors:  Arif Khan; Eswara Prasad Bomminayuni; Amritha Bhat; James Faucett; Walter A Brown
Journal:  Psychopharmacology (Berl)       Date:  2010-05-22       Impact factor: 4.530

2.  The influence of consumers' preferences and perceptions of oral solid dosage forms on their treatment.

Authors:  Inas Rifaat Ibrahim; Mohamed Izham Mohamed Ibrahim; Mahmoud Sa'di Al-Haddad
Journal:  Int J Clin Pharm       Date:  2012-06-29

Review 3.  Placebo effects: clinical aspects and neurobiology.

Authors:  Barry S Oken
Journal:  Brain       Date:  2008-06-21       Impact factor: 13.501

4.  Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness.

Authors:  A J de Craen; P J Roos; A L de Vries; J Kleijnen
Journal:  BMJ       Date:  1996 Dec 21-28

Review 5.  Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and Expectations.

Authors:  Kathleen N Moore; Michael J Birrer
Journal:  Oncologist       Date:  2018-03-28

6.  Patients' evaluation of shape, size and colour of solid dosage forms.

Authors:  A B Overgaard; J Højsted; R Hansen; J Møller-Sonnergaard; L L Christrup
Journal:  Pharm World Sci       Date:  2001-10

7.  Inadequate description of placebo and sham controls in a systematic review of recent trials.

Authors:  Rebecca K Webster; Jeremy Howick; Tammy Hoffmann; Helen Macdonald; Gary S Collins; Jonathan L Rees; Vitaly Napadow; Claire Madigan; Amy Price; Sarah E Lamb; Felicity L Bishop; Klara Bokelmann; Andrew Papanikitas; Nia Roberts; Andrea W M Evers
Journal:  Eur J Clin Invest       Date:  2019-09-30       Impact factor: 4.686

8.  A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials.

Authors:  Ana Macedo; Magí Farré; Josep-E Baños
Journal:  Eur J Clin Pharmacol       Date:  2006-01-10       Impact factor: 2.953

9.  Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers.

Authors:  Robert A Wise; Susan J Bartlett; Ellen D Brown; Mario Castro; Rubin Cohen; Janet T Holbrook; Charles G Irvin; Cynthia S Rand; Marianna M Sockrider; Elizabeth A Sugar
Journal:  J Allergy Clin Immunol       Date:  2009-07-25       Impact factor: 10.793

Review 10.  [Clinical significance of the placebo effect].

Authors:  J Oeltjenbruns; M Schäfer
Journal:  Anaesthesist       Date:  2008-05       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.